Your browser doesn't support javascript.
loading
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance.
Goldman, Aaron; Khiste, Sachin; Freinkman, Elizaveta; Dhawan, Andrew; Majumder, Biswanath; Mondal, Jayanta; Pinkerton, Anthony B; Eton, Elliot; Medhi, Ragini; Chandrasekar, Vineethkrishna; Rahman, M Mamunur; Ichimura, Takaharu; Gopinath, Kodaganur S; Majumder, Pradip; Kohandel, Mohammad; Sengupta, Shiladitya.
Afiliação
  • Goldman A; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. shiladit@mit.edu goldman1@mit.edu.
  • Khiste S; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Freinkman E; Mitra Biotech, Integrative Immuno-Oncology Center, Woburn, MA 01801, USA.
  • Dhawan A; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Majumder B; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Mondal J; Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA.
  • Pinkerton AB; School of Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Eton E; Mitra Biotech, Integrative Immuno-Oncology Center, Woburn, MA 01801, USA.
  • Medhi R; Mitra Biotech, 7, Service Road, Pragathi Nagar, Electronic City, Bengaluru, Karnataka 560100, India.
  • Chandrasekar V; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Rahman MM; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Ichimura T; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • Gopinath KS; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Majumder P; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Kohandel M; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Sengupta S; Medical and Biological Laboratories International, Woburn, MA 01801, USA.
Sci Signal ; 12(595)2019 08 20.
Article em En | MEDLINE | ID: mdl-31431543

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Via de Pentose Fosfato / Sistemas de Liberação de Medicamentos / Inibidores Enzimáticos / Glucose / Glucosefosfato Desidrogenase / Proteínas de Neoplasias / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sci Signal Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Via de Pentose Fosfato / Sistemas de Liberação de Medicamentos / Inibidores Enzimáticos / Glucose / Glucosefosfato Desidrogenase / Proteínas de Neoplasias / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sci Signal Ano de publicação: 2019 Tipo de documento: Article